The author of today’s article notes that, every year at the J.P. Morgan Healthcare Conference, “big mergers and acquisitions, as well as important clinical trial data and lucrative licensing deals, […]
read more
Which Of These Biotech Stocks That Jumped Last Week Are Worth Jumping On Now?
Of the three biotech stocks featured in today’s article, all of which made big moves higher last week, which has/have what it takes to continue climbing? The author examines what […]
read more
Some Top Healthcare Analysts Are Bullish On These 3 Stocks
Why are the three healthcare stocks highlighted in today’s article worth a look? Because not only are some top healthcare sector analysts bullish on them, but so is the broader […]
read more
3 Biotech Stocks With The Potential To Double (Or More) – And The Safest Bet Of The Bunch
“Smart investors know the biotech industry’s full of clinical-stage companies that can explode in value overnight in response to positive clinical trial results or Food and Drug Administration approvals,” notes […]
read more
3 Biotech Stocks To Watch As 2021 Gets Underway
When it comes to the biotech stocks that experienced strong growth in 2020, the author of today’s article notes that the “more obvious cases such as vaccine company Moderna have […]
read more
3 Pharmaceutical Stocks To Watch – Including 1 Off-The-Radar Name
When it comes to finding something worthwhile to invest in, the author of today’s article asks “what better stocks to think about than pharmaceuticals?” He proceeds to take a look […]
read more
“The Best Biotech Stock On The Market” – And 2 Other Picks To Consider Buying Right Now
“I genuinely think that [this] is the best biotech stock on the market. The company is rolling in dough,” declares the author of today’s article in regards to one of […]
read more
The Best Bets Right Now In The Ongoing COVID Vaccine Race For Aggressive – And Cautious – Investors
While the first coronavirus vaccine has received emergency use authorization from the FDA, the author of today’s article points out that “The coronavirus vaccine race isn’t over.” So which COVID […]
read more
The Co-Managers Of An Outperforming Fund Share 3 Biotech Firms Poised To Solve Future Disease Outbreaks
The Shelton Green Alpha Fund is up more than 100% year-to-date and is among the best-performing funds of 2020 – and a big reason for its outperformance is its biotech […]
read more
Is This One-Dose mRNA COVID Vaccine Stock A Must-Buy?
Like the Pfizer and Moderna vaccines, the COVID-19 vaccine candidate being developed by the mid-cap biotech featured in today’s article uses a messenger RNA (mRNA) platform. Unlike the Pfizer and […]
read more